Publications by authors named "Christopher B Arant"

Claim this Profile
C
Chronic thromboembolic pulmonary hypertension: A great mimic.
Christopher B Arant, Carver N Arant, Davis E Bobbitt

Respir Med Case Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
Christopher B Arant, Timothy R Wessel, Paul M Ridker, Marian B Olson, Steven E Reis

Clin Cardiol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE).
Timothy R Wessel, Christopher B Arant, Susan P McGorray, Barry L Sharaf, Steven E Reis

Clin Cardiol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary and alternative medicine use among individuals participating in research: implications for research and practice.
Gregory J Welder, Timothy R Wessel, Christopher B Arant, Richard S Schofield, Issam Zineh

Pharmacotherapy· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atorvastatin effect on circulating and leukocyte-produced CD40 ligand concentrations in people with normal cholesterol levels: a pilot study.
Issam Zineh, Gregory J Welder, Amy E DeBella, Christopher B Arant, Timothy R Wessel

Pharmacotherapy· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors.
Issam Zineh, Xiaoping Luo, Gregory J Welder, Amy E Debella, Timothy R Wessel, Christopher B Arant

Pharmacotherapy· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78).
Issam Zineh, Christina L Aquilante, Taimour Y Langaee, Amber L Beitelshees, Christopher B Arant

Cytokine· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.
Leslee J Shaw, Marian B Olson, Kevin Kip, Sheryl F Kelsey, B Delia Johnson, Christopher B Arant

J Am Coll Cardiol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.
Leslee J Shaw, C Noel Bairey Merz, Carl J Pepine, Steven E Reis, Vera Bittner, Christopher B Arant

J Am Coll Cardiol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) Study.
Eileen Handberg, B Delia Johnson, Christopher B Arant, Timothy R Wessel, Richard A Kerensky

J Am Coll Cardiol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.
Kevin E Kip, Oscar C Marroquin, Leslee J Shaw, Christopher B Arant, Timothy R Wessel

Am Heart J· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST).
Issam Zineh, Rhonda M Cooper-Dehoff, Timothy R Wessel, Christopher B Arant, Peter Sleight

Clin Cardiol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.
Timothy R Wessel, Christopher B Arant, Marian B Olson, B Delia Johnson, Steven E Reis

JAMA· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on "new and emerging theories of cardiovascular disease".
Timothy R Wessel, Christopher B Arant, Carl J Pepine

Biol Res Nurs· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study.
Christopher B Arant, Timothy R Wessel, Marian B Olson, C Noel Bairey Merz, George Sopko

J Am Coll Cardiol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Gregory O von Mering, Christopher B Arant, Timothy R Wessel, Susan P McGorray, C Noel Bairey Merz

Circulation· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis